A joint NHS England and NHS Clinical Commissioners working group has issued final guidance to local clinical commissioning groups (CCGs) to limit prescribing of items of limited clinical effectiveness and over-the-counter (OTC) products for minor and self-limiting conditions.1 The guidance was published following a consultation period, after which some exceptions were clarified or added but general recommendations remained the same.1,2 The aim of the guidance is to reduce NHS expenditure on OTC medicines that could be purchased from pharmacies and …